Cargando…

Severe Cutaneous Adverse Reactions: A Single-Center Retrospective Study of 173 Patients in China

BACKGROUND: Severe cutaneous adverse reactions (SCAR) to drugs are a crucial public health issue and the use of systemic corticosteroids in SCAR has been controversial. OBJECTIVE: To analyze clinical features, causative drugs, treatment, outcomes, and prognostic factors of SCAR in the case-series of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zhongyi, Shen, Jie, Yang, Yiwen, Yuan, Ruoyue, Xiang, Leihong Flora, Zhang, Chengfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992557/ https://www.ncbi.nlm.nih.gov/pubmed/33911647 http://dx.doi.org/10.5021/ad.2019.31.5.545

Ejemplares similares

Dysfunction of ATG7-dependent autophagy dysregulates the antioxidant response and contributes to oxidative stress-induced biological impairments in human epidermal melanocytes
por: Qiao, Zhuhui, et al.
Publicado: (2020)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death
por: Xuan, Yijie, et al.
Publicado: (2022)

Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia
por: AlJasser, Mohammed I.
Publicado: (2023)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Analysis of B cell subsets in severe cutaneous adverse reaction
por: Azukizawa, Hiroaki, et al.
Publicado: (2014)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists’ Viewpoint
por: Shafiq, Nusrat, et al.
Publicado: (2022)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus
por: Li, Jie, et al.
Publicado: (2018)

Identification and Validation of Autophagy-Related Genes in Vitiligo
por: Yang, Yiwen, et al.
Publicado: (2022)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
por: Su, Shih-Chi, et al.
Publicado: (2016)

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
por: Chen, Chun-Bing, et al.
Publicado: (2018)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

Sutton's law and severe cutaneous adverse drug reactions: Is the money in the blister?
por: Chow, Timothy G., et al.
Publicado: (2021)

Analysis of Cutaneous Adverse Drug Reactions Reported at the Regional ADR Monitoring Center
por: Modi, Anal, et al.
Publicado: (2019)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement
por: Hu, H, et al.
Publicado: (2012)

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
por: Dao, Ro-Lan, et al.
Publicado: (2015)

Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea
por: Yang, Min-Suk, et al.
Publicado: (2019)

Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs
por: Lee, Suh-Young, et al.
Publicado: (2018)

Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea
por: Kang, Min-Gyu, et al.
Publicado: (2019)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
por: Qiancheng, Deng, et al.
Publicado: (2017)

Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)
por: Kuijper, E.C., et al.
Publicado: (2020)

The Role of Frozen Section in the Rapid Diagnosis of Severe Cutaneous Adverse Drug Reactions
por: Nicholas, Rajam, et al.
Publicado: (2021)

Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis
por: Bomze, David, et al.
Publicado: (2022)

Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR)
por: James, Fiona, et al.
Publicado: (2022)

A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India
por: Sharma, Rohini, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7f71f7b557lahigthj680oedsu